
Cigna (CI) Stock Forecast & Price Target
Cigna (CI) Analyst Ratings
Bulls say
Cigna Group is a company with promising future prospects, driven by its strong performance in the first quarter of 2026, with outperformance in MLR and growth in specialty and care segments. The exit from the Exchange market and strategic review of EviCore further demonstrate the company's focus on core growth opportunities. Additionally, the company's strong PBM and specialty pharmacy services, with key contracts and new business wins, support its positive outlook. There are some risks, such as potential government headwinds and impacts of a protracted economic downturn on commercial membership, but overall, the company's focus on high-growth areas, integration with health plans, and share repurchase activity make it a strong investment opportunity.
Bears say
Cigna Group is currently trading at the lower end of its 5-year range and below its average, which reflects the ongoing challenges in its PBM and health insurance businesses. The company's recent wins in government-sponsored businesses provide some downside protection, but its transformational spend and changing rebate economics may continue to negatively impact earnings. However, there is potential for upside in specialty businesses and health insurance MLR, which could contribute to growth in the long-term target. Overall, there are still execution risks and regulatory uncertainties that could affect the company's performance.
This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.
Cigna (CI) Analyst Forecast & Price Prediction
Start investing in Cigna (CI)
Order type
Buy in
Order amount
Est. shares
0 shares